ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth -6.2% ·
share flow +7.8% ·
net new positions -6.7%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 71 | +3 | 20.21M | $262.94M | +7 | −5 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | — | — |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | — | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | — |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | — | — |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | — | — |
| Q2 2024 | 10 | — | 5.27M | $31.86M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 3.53M | — | $35.03M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passive) | 2.49M | — | $24.69M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passive) | 2.49M | — | $24.69M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passive) | 2.49M | — | $24.69M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 1.95M | +109.9% | $19.33M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Millennium Management ✦ | 1.40M | +12.9% | $13.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 1.06M | +18.6% | $10.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passive) | 977.76K | -0.9% | $9.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passive) | 977.76K | -0.9% | $9.70M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passive) | 953.23K | +13.5% | $9.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 583.67K | +8.1% | $5.79M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Marshall Wace ✦ | 406.12K | -5.1% | $4.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Marshall Wace ✦ | 406.12K | -5.1% | $4.03M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 100.00K | 0.0% | $992,000 | 0.0% | Held | 2 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 85.84K | — | $851,513 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Fidelity (FMR) ✦ | 85.84K | — | $851,513 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 69.19K | -28.2% | $686,326 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 69.19K | -28.2% | $686,326 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 69.19K | -28.2% | $686,326 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 69.19K | -28.2% | $686,326 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 65.34K | -71.7% | $648,193 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 46.91K | -63.2% | $465,397 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 40.70K | +5.9% | $404,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $1.91M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 38.52M shares, $430.26M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.